Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -3.17% is 39% above its 5-year average of -5.17%, near the high end of its 5-year range (-47.92%–7.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.20% below its 12-month average of -3.08%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -3.17%.
RETURN ON INVESTED CAPITAL (ROIC)
-3.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-3.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-14.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-5.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
2.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
5.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
5.46%
CURRENT VS TTM AVG
-3.20%
CURRENT VS 3Y AVG
+78.75%
CURRENT VS 5Y AVG
+38.58%
CURRENT VS 10Y AVG
-256.95%
CURRENT VS 15Y AVG
-155.28%
CURRENT VS 20Y AVG
-158.09%
SECTOR MEDIAN · HEALTHCARE
-28.69%
median of 497 covered companies
CURRENT VS SECTOR MEDIAN
+88.94%
vs the sector median at left
Anika Therapeutics, Inc.
Market Cap
$264.05M
Return on Invested Capital (ROIC)
-3.17%
TTM Avg
-3.08%
3Y Avg
-14.94%
5Y Avg
-5.17%
Market Cap
$258.93M
Return on Invested Capital (ROIC)
-43.56%
TTM Avg
-66.27%
3Y Avg
-114.94%
5Y Avg
-104.61%
Market Cap
$260.75M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-56.97%
3Y Avg
-50.85%
5Y Avg
-45.83%
Market Cap
$262.75M
Return on Invested Capital (ROIC)
-42.92%
TTM Avg
-30.10%
3Y Avg
-80.25%
5Y Avg
-64.52%
Market Cap
$267.99M
Return on Invested Capital (ROIC)
-43.69%
TTM Avg
-34.60%
3Y Avg
-35.16%
5Y Avg
-35.84%
Market Cap
$251.01M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
Market Cap
$272.75M
Return on Invested Capital (ROIC)
-89.43%
TTM Avg
-77.88%
3Y Avg
-57.02%
5Y Avg
-48.01%
Market Cap
$247.47M
Return on Invested Capital (ROIC)
-59.90%
TTM Avg
-142.39%
3Y Avg
-118.24%
5Y Avg
-103.50%
Market Cap
$249.24M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-3723.51%
3Y Avg
-1911.77%
5Y Avg
-1278.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | $264.05M | -3.17% | -3.08% | -14.94% | -5.17% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $258.93M | -43.56% | -66.27% | -114.94% | -104.61% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $260.75M | -170.19% | -56.97% | -50.85% | -45.83% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $262.75M | -42.92% | -30.10% | -80.25% | -64.52% |
| Century Therapeutics, Inc. (IPSC)vs › | $267.99M | -43.69% | -34.60% | -35.16% | -35.84% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.01M | -69.76% | -64.00% | -45.05% | -31.07% |
| AC Immune S.A. (ACIU)vs › | $272.75M | -89.43% | -77.88% | -57.02% | -48.01% |
| Invivyd, Inc. (IVVD)vs › | $247.47M | -59.90% | -142.39% | -118.24% | -103.50% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.24M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
| InflaRx N.V. (IFRX)vs › | $247.60M | -25.38% | -99.58% | -69.59% | -61.10% |
ROIC
-3.2%
ROE
-2.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -3.17% |
| 2026-03-31 | -7.64% |
| 2025-12-31 | -6.56% |
| 2025-09-30 | 7.05% |
| 2025-06-30 | -5.05% |
| 2025-03-31 | -3.64% |
| 2024-12-31 | -3.94% |
| 2024-09-30 | -47.92% |
| 2024-06-30 | -33.11% |
| 2024-03-31 | -34.06% |
| 2023-12-31 | -36.58% |
| 2023-09-30 | -10.17% |
| 2023-06-30 | -9.38% |
| 2023-03-31 | -9.15% |
| 2022-12-31 | -6.04% |
| 2022-09-30 | -6.80% |
| 2022-06-30 | -4.55% |
| 2022-03-31 | -0.70% |
| 2021-12-31 | 0.82% |
| 2021-09-30 | -1.92% |
| 2021-06-30 | -4.80% |
| 2021-03-31 | -10.83% |
| 2020-12-31 | -8.62% |
| 2020-09-30 | -1.45% |
| 2020-06-30 | 2.58% |
| 2020-03-31 | 7.30% |
| 2019-12-31 | 8.20% |
| 2019-09-30 | 9.51% |
| 2019-06-30 | 9.98% |
| 2019-03-31 | 9.63% |
| 2018-12-31 | 6.55% |
| 2018-09-30 | 7.00% |
| 2018-06-30 | 7.02% |
| 2018-03-31 | 7.15% |
| 2017-12-31 | 11.68% |
| 2017-09-30 | 12.08% |
| 2017-06-30 | 13.42% |
| 2017-03-31 | 13.07% |
| 2016-12-31 | 13.99% |
| 2016-09-30 | 15.81% |
| 2016-06-30 | 16.40% |
| 2016-03-31 | 16.71% |
| 2015-12-31 | 14.04% |
| 2015-09-30 | 13.10% |
| 2015-06-30 | 12.63% |
| 2015-03-31 | 13.97% |
| 2014-12-31 | 20.36% |
| 2014-09-30 | 20.75% |
| 2014-06-30 | 20.94% |
| 2014-03-31 | 19.59% |
| 2013-12-31 | 14.07% |
| 2013-09-30 | 12.47% |
| 2013-06-30 | 10.97% |
| 2013-03-31 | 9.85% |
| 2012-12-31 | 9.19% |
| 2012-09-30 | 8.28% |
| 2012-06-30 | 9.47% |
| 2012-03-31 | 8.34% |
| 2011-12-31 | 7.15% |
| 2011-09-30 | 6.06% |
| 2011-06-30 | 4.54% |
| 2011-03-31 | 3.59% |
| 2010-12-31 | 3.99% |
| 2010-09-30 | 3.33% |
| 2010-06-30 | 3.76% |
| 2010-03-31 | 3.51% |
| 2009-12-31 | 3.23% |
| 2009-09-30 | 4.62% |
| 2009-06-30 | 4.04% |
| 2009-03-31 | 3.74% |
| 2008-12-31 | 3.67% |
| 2008-09-30 | 4.51% |
| 2008-06-30 | 5.06% |
| 2008-03-31 | 5.76% |
| 2007-12-31 | 6.65% |
| 2007-09-30 | 5.34% |
| 2007-06-30 | 5.02% |
| 2007-03-31 | 5.51% |
| 2006-12-31 | 5.30% |
| 2006-09-30 | 5.22% |
| 2006-06-30 | 7.59% |
| 2006-03-31 | 8.07% |
| 2005-12-31 | 9.06% |
| 2005-09-30 | 10.99% |
| 2005-06-30 | 8.61% |
| 2005-03-31 | 8.00% |
| 2004-12-31 | 12.15% |
| 2004-09-30 | 10.06% |
| 2004-06-30 | 8.17% |
| 2004-03-31 | 5.13% |
| 2003-12-31 | 3.01% |
| 2003-09-30 | 2.17% |
| 2003-06-30 | -4.90% |
